trending Market Intelligence /marketintelligence/en/news-insights/trending/brgqjypdpbwbdbbdurubbq2 content esgSubNav
In This List

Belgium's Celyad plans global offering of ordinary shares

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Belgium's Celyad plans global offering of ordinary shares

Celyad SA is planning to sell 1.8 million ordinary shares in a global offering.

The Belgium-based biopharmaceutical company will offer ordinary shares in the form of American depositary shares, or ADSs, in the U.S., Canada and certain countries outside of Europe. Each ADS offered will represent the right to receive 1 ordinary share.

Concurrently, the company will offer ordinary shares in a private placement in Europe and certain countries outside of the U.S. and Canada.

Celyad intends to grant the underwriters an option to buy up to an additional 15% of the ordinary shares or ADSs proposed to be sold in the offering.

The closing of the global offering is subject to market and other conditions.

Wells Fargo Securities LLC and Bryan Garnier & Co. are acting as joint book-running managers, while Bank Degroof Petercam NV and LifeSci Capital LLC are acting as co-managers for the offering. Kempen & Co NV is Celyad's adviser for the offering.